Novo Nordisk and Eli Lilly cut U.S. GLP-1 weight-loss drug prices, aiming for higher volumes despite near-term sales impact.

A viral Oval Office incident showing RFK Jr. appearing to “flee” after a man collapsed during Trump’s press conference sparks online debate, prompting White House clarification that he left to get ...

The stock price for Danish drugmaker Novo Nordisk (NYSE: NVO) is down more than 8% since last Friday's close. What's going on with this former darling of the global pharmaceutical industry that surged ...

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...

A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President Donald ...

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry ...

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.

Shares of Eli Lilly (LLY) and Novo Nordisk (NVO) fell on Friday after the companies agreed to offer their blockbuster weight-loss drugs at sharply discounted prices in the U.S. as part of a major drug ...

In November 2025, a photo circulated online that some social media users said authentically showed U.S. President Donald Trump looking on as a man fainted during a White House news conference in ...

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...